The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Arnold & Porter

Work 020 7786 6100
Fax 020 7786 6299

Jeremy Willcocks

Work +44 (0)20 7786 6181
Arnold & Porter

Work Department

Corporate & Finance




Jeremy Willcocks undertakes a broad range of mergers and acquisitions, corporate finance, and corporate advisory work. Mr. Willcocks advises on share and asset sales, IPOs, public takeovers, shareholder disputes, and joint ventures. Mr. Willcocks also has extensive experience with debt capital markets transactions. His clients include public and private companies, private equity funds, and banks.


Mr. Willcocks advises clients from a variety of industries, including the life sciences, leisure, financial services, technology, and transport sectors. He has particular experience in advising on cross-border transactions.




LLB Warwick University (1987)

London: Corporate and commercial

M&A: lower mid-market deals, £50m-£250m

Within: M&A: lower mid-market deals, £50m-£250m

The 'proactive, commercial' team at¬†Arnold & Porter¬†¬†is ‚Äėexcellent ‚Äď very proactive, understand the client‚Äôs business, and is technically on top of new developments‚Äô. The key areas of practice for the firm‚Äôs M&A team are private equity M&A, life sciences/pharmaceuticals, healthcare, technology and retail.¬†Jeremy Willcocks¬†has ‚Äėexcellent mid-market M&A and equity capital markets experience‚Äô; he acted for Diversis Capital on its recommended cash offer for LSE-listed ServicePower Technologies and acted for the shareholders of Health Partners International on all aspects of the acquisition of the company by DAI Global Health. On the real estate side,¬†Anna Buscall¬†advised the McArthurGlen Group on its acquisition of the Rosada retail outlet centre in Roosendall, the Netherlands, while in healthcare¬†David Gerber¬†handled the UK and European law issues relating to Carestream‚Äôs sale of its dental digital business to funds managed by Clayton, Dubilier & Rice and CareCapital Advisors.

[back to top]

Private equity: transactions

Within: Private equity: transactions

Arnold & Porter's 'savvy' team has a first-class reputation, owing to its experience across a wide range of domestic and cross-border transactions. Led by Andrew Harris, the team advises on MBOs, MBIs, buy and builds, and disposals/exits, among various other matters. Harris and associate Andrew Ross acted for EMK Capital in its MBO of Israel-based Luminati in 2017. They were also part of a team (which included David Gerber), which advised the same client and Bregal Capital LLP on their sale of the IT training company QA Group to CVC Capital Partners.  Another key figure is Sean Scanlon, who was the lead adviser to Bluebird Partners on the sale of its Island View Holidays Group portfolio company (a holiday and caravan park owner-operator based in the Isle of Wight) to AG Holiday Parks UK Limited. Jeremy Willcocks is also recommended. Complementing the team's core transactional expertise is the firm's strengths in ancillary areas, such as intellectual property, restructuring and employment. Syndicated and leveraged finance expert Colin Tan recently made partner.

[back to top]

Venture capital

Within: Venture capital

Housed within the firm's wider corporate and private equity offering, Arnold & Porter regularly handles work for investors in the biotech sector. Led by Jeremy Willcocks, the firm is best-known in this space for later stage investments and in relation to exit strategies. Clients include Acuity Investments, Bluebird Capital and Bregal Capital.

[back to top]

London: Finance

Debt capital markets

Within: Leading individuals

Jeremy Willcocks - Arnold & Porter

Within: Debt capital markets

Arnold & Porter has 'one of the most experienced practices for sovereign debt deals and has partners who have been in that market longer than most'. The firm acts predominantly for sovereign issuers in international debt transactions and its stellar list of clients includes the Hashemite Kingdom of Jordan, the Republic of Azerbaijan, the State of Israel, the Republic of Costa Rica and the Federative Republic of Brazil. Its recent work includes innovative and challenging deals such as the $300m debut offering of diaspora bonds by the Republic of Nigeria. The deal represented the first time a sovereign issued tradeable, registered bonds approved for distribution to retail investors, particularly the Nigerian diaspora, in the US and UK, and it was the first retail bond of its kind from any sovereign. For the Republic of Turkey, the practice in London worked on a $1.25 billion sukuk offering, which involved the issuance of lease certificates representing interests in Turkish government real estate assets that were transferred to the issuer and leased back to the government. Jeremy Willcocks led both deals and is the key partner in London. He works closely with former US Executive Director of the World Bank Whitney Debevoise, who splits his time between London and Washington DC.

[back to top]

London: TMT (technology, media and telecoms)

Pharmaceuticals and biotechnology

Within: Pharmaceuticals and biotechnology

Arnold & Porter is particularly known for its work in regulatory and competition matters, and has additional expertise in patent litigation, product liability, and corporate and commercial matters. Ian Dodds-Smith leads the team and has notable strengths in regulatory and product liability matters. Adela Williams is also a key figure and is an expert in advising on clinical trials, marketing authorisations and promotional issues, and has additional expertise in dealing with product liability cases. Another notable name is Lincoln Tsang, who specialises in regulatory, compliance, enforcement and public policy issues. Also highly recommended are Jeremy Willcocks, of counsel Jacqueline Mulryne, Kathy Osgerby and Ewan Townsend. Tim Frazer has retired, while patent litigation partner Christopher Stothers left the firm for Freshfields Bruckhaus Deringer LLP alongside counsel Laura Whiting.

[back to top]

Back to index

Legal Developments by:
Arnold & Porter

  • The role of arbitrators in EU antitrust law

    In May 2014, it will be ten years since Regulation No 1/2003 entered into force. When the legislator of the European Union adopted this Regulation on 16 December 2002, its main objective was to decentralise the enforcement of the two main provisions of EU antitrust law, Articles 81 and 82 of the Treaty establishing the European Community (now Articles 101 and 102 of the Treaty on the Functioning of the European Union (TFEU)). Where do the arbitrators fit in this picture?‚Ä©
    - Arnold & Porter (UK) LLP

Legal Developments in London

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to